Alnylam Pharmaceuticals (ALNY) Land & Improvements (2016 - 2018)

Alnylam Pharmaceuticals (ALNY) posted Land & Improvements of $9.1 million for Q4 2018, little changed on a QoQ basis from $9.1 million in Q4 2017, and little changed year-over-year from $9.1 million in Q4 2017.

Alnylam Pharmaceuticals (ALNY) Land & Improvements (2016 - 2018) Analysis & Trends

Alnylam Pharmaceuticals' Land & Improvements history runs 3 years deep, the most recent figure standing at $9.1 million for Q4 2018.

  • Quarterly Land & Improvements changed 0.0% year-over-year to $9.1 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $9.1 million (changed 0.0% YoY) and the FY2018 annual result came in at $9.1 million, changed 0.0% from the prior year.
  • Land & Improvements was $9.1 million for Q4 2018 at Alnylam Pharmaceuticals, roughly flat from $9.1 million in the prior quarter.
  • Across five years, Land & Improvements topped out at $9.1 million in Q4 2016 and bottomed at $9.1 million in Q4 2016.
  • A 3-year average of $9.1 million and a median of $9.1 million in 2016 frame the typical range for Land & Improvements.
  • Peak annual rise in Land & Improvements reached 0.0% in 2017, while the deepest fall reached 0.0% in 2017.
  • Alnylam Pharmaceuticals' Land & Improvements stood at $9.1 million in 2016, then changed by 0.0% to $9.1 million in 2017, then changed by 0.0% to $9.1 million in 2018.
  • Business Quant data shows ALNY's Land & Improvements at $9.1 million in Q4 2018, $9.1 million in Q4 2017, and $9.1 million in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 9.08 Mn
Dec 31, 2017 9.08 Mn
Dec 31, 2016 9.08 Mn